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other than sinus, and no high grade obstructive CAD (-70% steno~,~) were 
(~xcluded from the study. Collateral flow was graded from 0 to 2 by two blinded 
mterventional cardiel0gisfs, 
Results: O135 l;~tients, 16 had heart r~les -~50 and the remaining 19 had 
ratea ~65, Both groups w~re pmdeminantly male with mean ~ge of 67 ~nd 
66, rasp~-'~'Ively, Lelt veeft'lo~!M ltm~on wa~ preserved with moan e(0¢l~on 
froctlof~ of 57% m both grou~. 94% of the btadYc~rdi~ p~tiertt~ de~eloped 
co!l~ter~ts with 69% ~nst rdt lng  grade ~ al~l 25% gr~ 1 Collaterals 
In the cqntffil group, 57% d~v~toged ¢;;~t!~ter~!s with 47% gra~ ~ and 10% 
grild~ 1 ~d!i~tori~!li, ~t~tistlcal ~l~llysis rwe~l!s lgr~ificaolly gaoler (.~oll~torats 
in br~dy~-~c p,~tienl~ o~111~ted 10 m~tel~l control~ (p .~ 0.0~5). 
C,m~s~1: Ttlis ~tt~J,/d(m~nstmtes A cef~'el~tton ~tween br~dy¢~rd*~ 
arid collateral ~S~I growth in p~t~nts with CAD, This finding has II~t#nfial 
clinical irnpl¢~fions in t!'~ m~an~g~ment of chren~(~ CAD, ttr~dVcardic a~nts 
n~y b~ U~tBl~l in p/orP,.olit,~g ~r@ogen~s~s, 
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A g, AnllM-Indtu~;ed OeaenslUzalion o! Human Cardiac 
/~=- drenoceptors: In Vivo Studies in IMsIthy 
VOlunteotS 
J Jakul~t~ U. Polar. J, Radke. K P0n~cke. O ,E  Broctde. In~bfu~e Ot 
PhamtacQ~, Unwemity at Haffe*Wiff~ntterg. Hal@. Germany 
Background: In the human heart a con~-~=~bte amount el tE,-adrenoceptors 
fAR) exist mediat~l inmeases in heart rate (HR) and ct~tractility (CON). We 
stud~ed whether chmn¢ agomsHreatmenl r,',=., desensitize card~ac tt~.AR. 
Methods: We assessed =n 16 mate healthy volunteers HR-increases and 
shortenmg el HR-corrected efeclromechanical systole (OS.~c as measure of 
=eetrop~sm) induced 'at the full- t~-AR agenrsts ted0~taline (I"ER acting at 
~-AR) and isopreea/me (ISO actmg at p'* and t~-AR) and the par~al ~AR 
agonist cehpralol (CEL acting at ~-AR) before and alter 14d TIER (3 ~ 5 
rag/flay p.o.)-treatmant. 
Resutts: Ek~tore TER-t~eatmera TER.mfusion (50--150 ng/kg/min) m- 
creased HR and shortened QS~ c mealy ~ia t~-AR stimulahon but a small 
tit -All component was also in¢ludecl, tSO-mfustOn (3.5-35 ng/kg/min)..ev0ked 
HR-lncraases in~olved #~- and t~-AR to the same extent while QS~c-sh~rten- 
mg was mediated meaty by tfl-AR stimulatmn CEL (600 mg p.o.) evoked HR- 
~ncfea~es and QS;c-shortening wa t~-AR stimulation but to a lesser extent 
than ISO or TER After TER-treatment TER- and ISO.intusion evoked HR- 
mereases and QS~e-sh~rtening was sige=ficantly attenuated whereby TER- 
effects were markedly more desensitized than IS@effects. CEL.mduced 
HR-increase and OS;.c-shertentng was abohshed; moreover CEL reduCed 
basal (alter TER-treatment elevated) HR and CON. 
Conclusron: 1) Human cardiac t~-AR are subtype-sele,3~,e;y desen,~t~zed 
following 14 d treatment w~th a/'~-AR agonist 2) lSO-evoked CON-~noreasP.S 
tnolud~ a t~-AR component and 3) the partial P-AR agomst eEL behaves in 
the presence ot an activated/'~-AR system like a ~-AR antagonist. 
~ Janus Kinase 2 Is Activated by Angioteosln II via G 
Proteins of the Gi Subfamily in Rat Neonatal 
Ca~liac MyoCytes 
J. Carlson t . J. Theilade ~ ,$, 1Bell z. S. Haunso ~ . S.P. Sheikh t z, ~Dept. of 
Medzcme B, National Unn,ersi~/ Hospital. Copenhagen. Denmark: "~Dept. 
Cell. & MoI. Pnann., University of California. San Francisco. CA 94143. USA 
Background Janus kinase 2 (Jak?-) is activated by cell surface receptors of 
the cytokine family and G protein-coupled receptors, and may be involved 
in confemng the hypedrophic properties ot these receptors. Wh~le Jak,?. 
activation is achieved by direct assooat~on with intracellular domains of the 
cytokine receptors, the mechanism of Jak2 activation by G pr0tein-coupled 
receptors is unknown. 
Methods: Pnmary cell cultures from neonatal rat hearts were stimulated 
with Angiotensin II fAng II) alter transtection with cD=,IA's coding tor G protem 
subunits and/or treatment with p~."tussis toxin. Jak2 and signal transducers 
and activators of transcription (STATs) activation were detected by i,mmuno- 
precipitation and western blotting. 
Results: Jak2 and STAT1 & 3 were activated by Ang II in rat cardiomy- 
oeytes in a time-dependent manner. Pertussis toxin blocked this activation, 
Transfection with/~-adrenergic receptor kinase minigen (flARK miniger,) also 
prevented Jak2 activation by Ang II. 
Conclusion: Our data demonstrate that G proteins of the G, subfamily 
play a role in Jak2/STAT activation by Ang I1. Interestingly, it is likely that 
beta:/,*subun~t hl)~r~t~on tS a rrecesS~n t step for JalVSTAT actwatton Thence 
results suggest hat tho G, faredy arKI #~. p ~ys ~ role n changmg tr~nscnp1!on 
following hormonal ~timulation of the I~earl 
• Differential Regulstton of ¢a~111¢ IIofomt= of 
l~'oteln Klnaae C In l=opmtemoH~u, md ¢a~1!i¢ 
HYl~l' lrophy 
MU, Bragn, K I~!irkp,~¢, B, Pauke, G, Simoni~, R,H Str~ssftr Un#~f~y ot 
HCK!ett~erg, H~t~er  9. Gem~lny 
Ba¢~eund; P-adrener(;~ receptor ~fim~l~ti0n W chm_~ mf~,~,on Ot SOpm, 
t~fer~l (1~0) re~lt~ in c~r~i~¢ hyperlr01~y, It Ihi~ chf0niC ~timulal~l~n el cAMP 
dep~edent ~gnal!ing I'J~thwi~y ff'~y mo(~late lh~ aclMly ~t,~ expre~s,~ Ot 
cenfr4f o ~  tn grow~ft a~ d~ffe,entiafK~. I 0lein kinsse C. h~s net 
cbar~;~lenzed, 
Method: To a~reS~ thi~ questi0n, ISo w~s ~ut~utan~ush/a¢lmm~lered 
to r~l~ by osmotic minil~ump~ (:~ mg Iso/kg ,, d), Afte~ ? days caKfiac PKC~ 
a¢l~vffy and the e~q~ms~on f PKG.isoform~ both at tile protem level using 
Western blot analysis with subtypo~spe~dm ~ntll:~O~leS and the mRNA-lavel 
u~ing RT-PCR w~r~ ~termir,~, 
Result.~; Card~a¢ hypedrephy was shown by the increased heaff-tO.boUy 
we~tht ratio in Iso-treatea rats (2.7 g/kg ~ 02. vs 3.4 gJkg ~ 0~.; p ~ 0.05, 
n = ~). The speQf¢ PKC-actMty in the Cytosol it, re'eased up t n t30% (2B9 
5,9 vs 221 ~+ 43 pmollmg protein . rain). E~q~rass~on OfPKC,-~ and PKC-,~ 
increased in hypertrophic hearts significantly, whereas the isotorms PKC-~, 
and PKC~zeta; remained unaltered. Furthermore, in Iso-treated mrs (n : 8), 
the mRNA-level I~lh o! P~C,-,~ (97'8 _ 128 va 486 _+ 56 agmg totaI-RNA, p 
005} andof PKC~ (f654 ~ 144vag88 :~ 112 ag/ng fotaI.,RNA, p ~ 0,05) 
were slgnifcantly increased. In ¢onlr~st, he steady-slale mRNA levels tot 
PKC,~ were unchanged (246 ± 36 vs 2q9 ~ 40 ag/ng tataI-RNA). 
C.Onclus~on~: l"he..7~e data show that cardiac hypedrophy induced by 
chronic tl-adrene~gK: stimulatlo~ promotes an inoreased actn~/of pmlem 
kma~se C wrth e newly ellaracter~ed, sUbtype-seleclive expressional regula~ 
t~on ot the novel PKC-P~otorms PKC~ and PKC-, 
[1038-9 1 A Recombinant. CMV Promoter-driven G 
Protein-coupled Receptor in Cardiomyocytes Is Not 
Downregulated bv Agonists 
M Ungerer, K.-L. Laugwttz, H.-J. Weig, K, Kronsbeln, K. Hoffmatln, 
A Schomtg C/eursche,s Hetz, z'entrum anti 1. ~ ,~nE,  ct',e Klimk, 
Technische Un~'ersrtaf Munich, Germany 
Obiect/ve: We c~mpared the homologous desensitization and downmgula- 
t~on el endogenous t{-raceptors (pAR) with Ihat OTa recombinant, hetemlo- 
gous G'~-coupling receptor in cardL~my~ytes 
Methods: We used a recombinant adenev]rus for the human V2 va. 
sepressm .eceptor under the express~on control of a CMV promoter (Ad~ 
CMV-V2R). Ad-CMV-V2R-mfected cardmmyocytes were subiecled to age, 
nist ~mulatmn of natwe pAR and of mc~nbnant V2 vaSopressin receptorS 
(rV2R). For this pu~ose, the cells were exposed to either isopmtemnol (iso) 
for natrve pAR or argtnme vasowessm (AVP) for rV2R for different periods of 
time, Agenist exposure led to a ral~d desensitization ot endogenous t~AR on 
the short run. and to further eduction el cAMP accumulation after longer incu- 
bation peneds wh~'h was due to pAR dewnregutafion. Incontrast, rV2R were 
desensitized tnitia~y, but ware not subject o doworeguletton, rV2R density 
did not change significantly after 20 hourS of agorsst exposure (Table). 
Agomsi exposure: 0 rain 15 mm 20 h 
ReCeptor ~nsl~,, ffmol~mg protemJ 
pAR. TSO pre-expmJure 60 • 5 55 • 6 25 ± 6" 
rV~R. AVP pre-oxl~oCjure 789 ~ ;tOO 723 : 160 741 .: 168 
AgomsNnduced cAMP accumulation ftoM over ba,£,~tll 
riAR, ~ gre~,xpo~ure 42 = 09 t 7 ~" 05' 1 1 : 02'" 
rV;~R. AVP pro-exposure 7 : t 6 5 1 *.: 0 2" 52 ~ 1 1' 
(n ~ 3-5. 'p • 6 05 "'p - 0 01 v$ 0 mmuto.~ 
Conclusion: Heterologous recombinant rV;tR are desensitized but not 
downregulated incardiomyocytes. Therefore. we presume that rV2R am not 
SUDleCt to endogenous regulation el expmss~on, but only to protein modifi- 
cation Consequently, rV2R might be used for bypassing t~AR to stimulate 
cAMP over longer time peneds 
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